Compare Quest Diagnostics Inc (DGX) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while YieldMax MSTR Option Income Strategy ETF trades at $12.54. The key difference: Quest Diagnostics Inc pays a 1.45% dividend while YieldMax MSTR Option Income Strategy ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| DGX | MSTY | |
|---|---|---|
Market Cap | $26.21B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $238.50 | $95.95 |
52-Week Low | $173.49 | $11.55 |
Enterprise Value | $31.97B | — |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →
